Gregor Eisenwort
Overview
Explore the profile of Gregor Eisenwort including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bauer K, Machherndl-Spandl S, Kazianka L, Sadovnik I, Gultekin S, Suessner S, et al.
Leukemia
. 2023 Sep;
37(11):2250-2260.
PMID: 37673973
Myelodysplastic syndromes (MDS) are myeloid neoplasms presenting with dysplasia in the bone marrow (BM) and peripheral cytopenia. In most patients anemia develops. We screened for genes that are expressed abnormally...
2.
Willmann M, Peter B, Slavnitsch K, Berger D, Witzeneder N, Stefanzl G, et al.
Leukemia
. 2023 Mar;
37(5):1162-1165.
PMID: 36918646
No abstract available.
3.
Degenfeld-Schonburg L, Gamperl S, Stefanzl G, Schruef A, Sadovnik I, Bauer K, et al.
Am J Cancer Res
. 2023 Mar;
13(2):355-378.
PMID: 36895976
Systemic mastocytosis (SM) is a hematopoietic neoplasm with a complex pathology and a variable clinical course. Clinical symptoms result from organ infiltration by mast cells (MC) and the effects of...
4.
Ivanov D, Milosevic Feenstra J, Sadovnik I, Herrmann H, Peter B, Willmann M, et al.
Am J Hematol
. 2023 Feb;
98(5):770-783.
PMID: 36814396
Myeloproliferative neoplasms (MPN) are characterized by uncontrolled expansion of myeloid cells, disease-related mutations in certain driver-genes including JAK2, CALR, and MPL, and a substantial risk to progress to secondary acute...
5.
Sadovnik I, Ivanov D, Smiljkovic D, Stefanzl G, Degenfeld-Schonburg L, Herndlhofer S, et al.
Cells
. 2023 Jan;
12(1).
PMID: 36611797
Basophilia is a crucial prognostic variable in Ph-chromosome-positive chronic myeloid leukemia (CML). The ectoenzyme CD203c is an activation-linked surface antigen that is expressed specifically on basophil-committed progenitor cells and mature...
6.
Smiljkovic D, Herrmann H, Sadovnik I, Gamperl S, Berger D, Stefanzl G, et al.
J Allergy Clin Immunol
. 2022 Aug;
151(1):202-211.
PMID: 35953001
Background: Mast cells (MC) and basophils are effector cells of allergic reactions and display a number of activation-linked cell surface antigens. Of these antigens, however, only a few are functionally...
7.
Schneeweiss-Gleixner M, Filik Y, Stefanzl G, Berger D, Sadovnik I, Bauer K, et al.
Cancers (Basel)
. 2022 Jul;
14(13).
PMID: 35804842
In most patients with advanced systemic mastocytosis (AdvSM), neoplastic mast cells (MC) express D816V. However, despite their disease-modifying potential, KIT D816V-targeting drugs, including midostaurin and avapritinib, may not produce long-term...
8.
Peter B, Eisenwort G, Sadovnik I, Bauer K, Willmann M, Rulicke T, et al.
Am J Hematol
. 2022 Jul;
97(9):1215-1225.
PMID: 35794848
In most patients with chronic myeloid leukemia (CML) clonal cells can be kept under control by BCR::ABL1 tyrosine kinase inhibitors (TKI). However, overt resistance or intolerance against these TKI may...
9.
Milosevic Feenstra J, Jager R, Schischlik F, Ivanov D, Eisenwort G, Rumi E, et al.
Am J Hematol
. 2022 Jan;
97(4):390-400.
PMID: 35015307
Myeloproliferative neoplasms (MPN) are chronic stem cell disorders characterized by enhanced proliferation of myeloid cells, immune deregulation, and drug resistance. JAK2 somatic mutations drive the disease in 50-60% and CALR...
10.
Willmann M, Yuzbasiyan-Gurkan V, Marconato L, Dacasto M, Hadzijusufovic E, Hermine O, et al.
Front Vet Sci
. 2021 Dec;
8:755258.
PMID: 34957277
Mast cell neoplasms are one of the most frequently diagnosed malignancies in dogs. The clinical picture, course, and prognosis vary substantially among patients, depending on the anatomic site, grade and...